VISIBLE
Supports United Kingdom studies on coronary microvascular disease in women and translation into clinical care.
VISIBLE is a $55 million program co-funded by Wellcome Leap, Pivotal Ventures, and the British Heart Foundation that targets coronary microvascular disease (CMD) in women — a condition currently diagnosed and effectively treated in fewer than 1% of affected patients. The program's stated goal is to increase the proportion of women receiving effective CMD diagnosis and treatment from under 1% to mo…
Diagnosis and treatment of coronary microvascular disease in women, with the goal of increasing the proportion receiving effective care from under 1% to over 80%.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
Similar grants
Browse the directory →
Human Virome Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Offers exploration of the healthy human virome and virus host interactions across translational studies.
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement
🇺🇸NIH · United States
Funds the continuation of a dental clinical trial the institute already supports, or a competing revision that changes what it does.
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
🇺🇸NIH · United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3)
🇺🇸NIH · United States
Funds the clinical validation of a cancer biomarker assay whose analytical performance has already been proven.
DoW Military Burn, Technology/Therapeutic Development Award
🇺🇸MRDC / CDMRP · United States
Funds turning preclinical burn-care findings into an actual product — a device, a drug, or a clinical practice guideline.